Michael Marco ID Epi class slides on HPV Natural History
-
Upload
mikemarco -
Category
Health & Medicine
-
view
1.371 -
download
1
Transcript of Michael Marco ID Epi class slides on HPV Natural History
![Page 1: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/1.jpg)
Epidemiology & Natural History of HPV Infection and its Causal Relationship with
Invasive Cervical Cancer
Michael Marco, M.Phil., MPH, ID/Epi Pre-doctoral Training Fellow, CIDER, ICAP
Infectious Disease Epidemiology - P840615 April 2010
![Page 2: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/2.jpg)
Outline
HPV prevalence in women & men Risk factors for acquiring HPV Age & HPV Limitations of HPV serologic testing & current
understanding of immunity HPV detection HPV persistence, clearance & reactivation High-risk HPV & invasive cervical cancer (ICC)
Prevalence of disease & type-specific HPV
ICC natural history: SIL & CIN ICC screening: PAP vs. HPV (measurement error)
![Page 3: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/3.jpg)
• A DNA Virus
• Preferentially infects squamous epithelial cells
Human Papillomavirus (HPV)
![Page 4: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/4.jpg)
CDC 2008Median Age of Sexual Debut for Girls is 17.6 years
![Page 5: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/5.jpg)
Winer, et al. 2003
![Page 6: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/6.jpg)
CDC 2008
(Debatable; more for progression to cancer)
Non-penetrative transmission has been documented, but is less likely
(e.g., HIV) HPV in HIV+ women (pre-and post-HAART) is worthy a separate lecture. See Steben & Franco-Duarte review
![Page 7: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/7.jpg)
![Page 8: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/8.jpg)
![Page 9: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/9.jpg)
HPV Prevalence in Women Varies Markedly in-and-between Populations
Possiblyan artifact of different assays (“home brewed”) used to measure HPV?
![Page 10: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/10.jpg)
![Page 11: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/11.jpg)
Methodological Issues to Consider with HPV Prevalence in Men
![Page 12: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/12.jpg)
in
![Page 13: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/13.jpg)
CDC 2008
HPV Prevalence is Similar Among U.S. Racial/Ethnic Groups
![Page 14: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/14.jpg)
HPV Prevalence by Age
CDC 2008
![Page 15: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/15.jpg)
Why Does HPV Prevalence in Women Differ by Age & their Country of Origin?
![Page 16: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/16.jpg)
High Risk HPV Prevalence Differ by Age in Women, but not Men
![Page 17: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/17.jpg)
CDC 2008
![Page 18: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/18.jpg)
![Page 19: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/19.jpg)
HPV Detection With an HPV DNA test
(Hybrid Capture II (The only FDA-approved HPV Test) Can analyze residual fluid of a liquid-based
cytology specimen from a Pap smear Detects only “high risk” (hr)HPV types, but does
not identify the individual type. Only research assays (“home brewed”) offer information on the specific genotype Would be useful for determining vaccine effectiveness in
the community? Indications for use
Routine adjunct to Pap in women 30 and overManagement of ASCUS (atypical squamous cells of
undetermined significance)
![Page 20: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/20.jpg)
Collection of HPV for DNA Amplification
X
![Page 21: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/21.jpg)
Hybrid Capture II
![Page 22: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/22.jpg)
What Dose HPV Persistence, Clearance & Reactivation Mean???
![Page 23: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/23.jpg)
Persistence of hrHPV Type is a Strong Risk Factor for Precancerous Lesions
Ho, et al. NEJM 1998
![Page 24: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/24.jpg)
![Page 25: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/25.jpg)
Why Should We Care About HPV Infection?
![Page 26: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/26.jpg)
From 1000 Cases of Cervical Cancer, HPV DNA was Found in 99.7%
![Page 27: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/27.jpg)
CDC 2008
![Page 28: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/28.jpg)
Cervical Cancer is the 3rd Leading Cancer in Women
WHO IARC, 2006
![Page 29: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/29.jpg)
![Page 30: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/30.jpg)
![Page 31: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/31.jpg)
Natural History of HPV Infection and Cervical Cancer
![Page 32: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/32.jpg)
Natural History of HPV Infection and Cervical Cancer
![Page 33: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/33.jpg)
SIL: cytological (cells from Pap smear) CIN: histological (tissue from colposcopy)
![Page 34: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/34.jpg)
![Page 35: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/35.jpg)
![Page 36: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/36.jpg)
Colposcopy +/- Biopsy are Warranted after an Abnormal Pap or Repeat hrHPV Detection
![Page 37: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/37.jpg)
Measurement Error is Common in the Reading of Colposcopic Biopsies
Shiffman, et al. 2007
![Page 38: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/38.jpg)
CIN can Clear Spontaneously or Regress
CIN 1 lesions spontaneously clear in 60% of the cases and rarely progresses to cancer (1%)
CIN 2 & CIN 3 lesions spontaneously clear in 30-40% of cases, however a higher percentage progress to cancer >12% if untreated
Cannot tell by the “look” of the lesions which ones will progress
CIN 2 is defined as an “intermediate diagnosis,” but is treated for safety as if it was CIN 3
Development of CIN 2 or CIN 3 are most often used as “surrogate endpoints” for invasive cervical cancer in prospective cohort studies
An immediate vs. differed treatment study for CIN 2 lesions would be beneficial, however, no IRB would approve it.
Moskowitz 2007; Woodman 2007, Wacholder 2003
![Page 39: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/39.jpg)
![Page 40: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/40.jpg)
Our study found that a single round of HPV testing was associated with a significant decline in the rate of advanced cervical cancers and associated deaths, as compared with the unscreened control group. By contrast, there was no significant reduction in the rate of death in either the cytologic-testing group or the VIA group, as compared with the control group. NOTE: no cancer-related deaths were observed in any of the HPV-negative women.
![Page 41: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/41.jpg)
Shiffman & Wacholder 2009
![Page 42: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/42.jpg)
With HPV Testing, is it Now Time to Retire the Pap?
![Page 43: Michael Marco ID Epi class slides on HPV Natural History](https://reader036.fdocuments.in/reader036/viewer/2022070322/5590f9f11a28ab4e038b45f2/html5/thumbnails/43.jpg)
What about HPV & the Need for Vaccination in Animals?
Dad, I am nearing my sexual debut. Can I be the first puppy to get the HPV vaccine?